Evolent Health, Inc. Proceeds from Long-Term Debt Issued
Evolent Health, Inc. (EVH) reported Proceeds from Long-Term Debt Issued of $647.49 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfLongTermDebt · last filed 2024-02-23
- Evolent Health, Inc. proceeds from issuance of long-term debt for the quarter ending 2023-12-31 was $391.43M.
- Evolent Health, Inc. proceeds from issuance of long-term debt for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- Evolent Health, Inc. proceeds from issuance of long-term debt for the quarter ending 2023-06-30 was -$267.00K.
- Evolent Health, Inc. proceeds from issuance of long-term debt for the quarter ending 2023-03-31 was $256.33M.
- Evolent Health, Inc. proceeds from issuance of long-term debt for fiscal 2023 was $647.49M, a 194.66% increase from fiscal 2022.
- Evolent Health, Inc. proceeds from issuance of long-term debt for fiscal 2022 was $219.74M.
- Evolent Health, Inc. proceeds from issuance of long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Evolent Health, Inc. proceeds from issuance of long-term debt for fiscal 2020 was $30.06M.
| Period end | Proceeds from Issuance of Long-term Debt 3 month | Proceeds from Issuance of Long-term Debt 6 month | Proceeds from Issuance of Long-term Debt 9 month | Proceeds from Issuance of Long-term Debt 12 month |
|---|---|---|---|---|
| 2023-12-31 | $391.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $391.43M derived: sum of 2 quarters · filed 2024-02-23 | $391.16M derived: sum of 3 quarters · filed 2024-02-23 | $647.49M 10-K · filed 2024-02-23 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$267.00K derived: sum of 2 quarters · filed 2023-11-02 | $256.06M 10-Q · filed 2023-11-02 | $256.06M derived: sum of 4 quarters · filed 2024-02-23 |
| 2023-06-30 | -$267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $256.06M 10-Q · filed 2023-08-03 | $256.06M derived: sum of 3 quarters · filed 2024-02-23 | $475.80M derived: sum of 4 quarters · filed 2024-02-23 |
| 2023-03-31 | $256.33M 10-Q · filed 2023-05-04 | $256.33M derived: sum of 2 quarters · filed 2024-02-23 | $476.07M derived: sum of 3 quarters · filed 2024-02-23 | $476.07M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $219.74M derived: sum of 2 quarters · filed 2024-02-23 | $219.74M derived: sum of 3 quarters · filed 2024-02-23 | $219.74M 10-K · filed 2024-02-23 |
| 2022-09-30 | $219.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $219.74M derived: sum of 2 quarters · filed 2023-11-02 | $219.74M 10-Q · filed 2023-11-02 | $219.74M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $0.00 10-Q · filed 2023-08-03 | $0.00 derived: sum of 3 quarters · filed 2024-02-23 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 2 quarters · filed 2024-02-23 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $0.00 10-K · filed 2024-02-23 | ||
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | |||
| 2020-12-31 | $30.06M 10-K · filed 2023-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |